Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography tandem mass spectrometry

被引:57
作者
Callejas, SL [1 ]
Biddlecombe, RA [1 ]
Jones, AE [1 ]
Joyce, KB [1 ]
Pereira, AI [1 ]
Pleasance, S [1 ]
机构
[1] Glaxo Wellcome Res & Dev Ltd, Dept Int Bioanal, Div Bioanal & Drug Metab, Ware SG12 0DP, Herts, England
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 718卷 / 02期
关键词
fluticasone propionate; glucocorticoid;
D O I
10.1016/S0378-4347(98)00374-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive, robust and high throughput mass spectrometry based method is described for the determination of the glucocorticoid fluticasone propionate in plasma. The method employs solid-phase extraction in 96 well microtitre plate format which has been automated by means of a custom built Zymark robotic system. The extracts are analysed by liquid chromatography-tandem mass spectrometry using thermally and pneumatically assisted electrospray ionisation and selected reaction monitoring. The method is both accurate and precise with both intra- and inter-assay precision (C.V.) of less than <6%. The method provides a lower limit of quantification of 20 pg/ml from 0.5 mi of human plasma, sufficient to monitor systemic concentrations of inhaled fluticasone propionate at therapeutic doses. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 12 条
[1]  
Allanson JP, 1996, RAPID COMMUN MASS SP, V10, P811, DOI 10.1002/(SICI)1097-0231(199605)10:7<811::AID-RCM561>3.0.CO
[2]  
2-Q
[3]   A SENSITIVE RADIOIMMUNOASSAY, INCORPORATING SOLID-PHASE EXTRACTION, FOR FLUTICASONE 17-PROPIONATE IN PLASMA [J].
BAIN, BM ;
HARRISON, G ;
JENKINS, KD ;
PATEMAN, AJ ;
SHENOY, EVB .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (07) :557-561
[4]  
BARNES PJ, 1993, BRIT MED J, V307, P815
[5]  
BIDLECOMBE RA, 1996, P ISLAR C MASS AUT B
[6]   FLUTICASONE PROPIONATE - AN UPDATE ON PRECLINICAL AND CLINICAL-EXPERIENCE [J].
FULLER, R ;
JOHNSON, M ;
BYE, A .
RESPIRATORY MEDICINE, 1995, 89 :3-18
[7]   THE HUMAN PHARMACOLOGY OF FLUTICASONE PROPIONATE [J].
HARDING, SM .
RESPIRATORY MEDICINE, 1990, 84 :25-29
[8]  
JENKINS KD, 1992, BIOANALYTICAL APPROA, V22, P205
[9]   Issues in the use of inhaled glucocorticoids [J].
Kamada, AK ;
Szefler, SJ ;
Martin, RJ ;
Boushey, HA ;
Chinchilli, VM ;
Drazen, JM ;
Fish, JE ;
Israel, E ;
Lazarus, SC ;
Lemanske, RF ;
Cherniak, RM ;
Hurd, SS ;
Peters, SP ;
Sorkness, C ;
Szefler, SJ ;
Zwillich, CW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) :1739-1748
[10]   A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography atmospheric pressure chemical ionisation mass spectrometry [J].
Li, YN ;
Tattam, BN ;
Brown, KF ;
Seale, JP .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (03) :447-452